Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-03-004905
Filing Date
2003-04-29
Accepted
2003-04-29 15:31:07
Documents
4
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.2 TO FORM 10-K y85913a2e10vkza.txt 10-K/A 242049
3 INDEPENDENT AUDITORS' CONSENT y85913a2exv23.txt EX-23 1816
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER y85913a2exv99w1.txt EX-99.1 1362
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER y85913a2exv99w2.txt EX-99.2 1447
  Complete submission text file 0000950123-03-004905.txt   248733
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-15190 | Film No.: 03669385
SIC: 2835 In Vitro & In Vivo Diagnostic Substances